Skip to main content

Want a detailed portfolio tracker?

Applied Therapeutics (APLT) P/E (2019 - 2026)

Applied Therapeutics (APLT) P/E from May 14, 2019 to Jul 21, 2026. The TTM Applied Therapeutics (APLT) P/E is -0.89. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Applied Therapeutics (APLT)

YearP/EChange
2026-0.89+3.00%
2025-0.87-0.90%
2024-0.88-59.86%
2023-2.18+724.64%
2022-0.26-88.07%
2021-2.22-57.69%
2020-5.24-29.82%
2019-7.46N/A

Comparison Applied Therapeutics (APLT) P/E with competitors

Applied Therapeutics (APLT) P/E is -0.89.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.19%
NBYStablecoin Development Corp0.00-100.48%
ENLVEnlivex Ltd0.07-108.37%
FGENFibroGen Inc0.24-126.87%
CHRSCoherus Biosciences Inc0.85-194.98%
FBIOFortress Biotech Inc0.95-206.23%
ORMPOramed Pharmaceuticals Inc1.50-268.24%
AGENAgenus Inc3.01-436.87%
INVAInnoviva Inc3.15-453.03%
VXRTVaxart Inc3.55-497.33%
CRMDCorMedix Inc3.63-506.14%
CVACCureVac N.V.4.45-597.61%
GLPGGalapagos NV4.86-643.86%
SRPTSarepta Therapeutics Inc4.88-646.46%
ABEOAbeona Therapeutics Inc5.39-703.03%
ABUSArbutus Biopharma Corp5.60-726.33%
ZVRAZevra Therapeutics Inc5.89-758.97%
SPROSpero Therapeutics Inc6.23-797.16%
CGENCompugen Ltd6.31-806.73%
RIGLRigel Pharmaceuticals6.87-869.20%
SLXNSilexion Therapeutics Corp7.30-916.66%
OMEROmeros Corporation9.26-1136.35%
AUPHAurinia Pharmaceuticals Inc9.58-1172.86%
PLXProtalix BioTherapeutics Inc10.89-1319.05%
ACADAcadia Pharmaceuticals Inc11.73-1412.80%
TBPHTheravance Biopharma Inc12.26-1472.52%
ADMAAdma Biologics Inc12.42-1489.99%
HRMYHarmony Biosciences Holdings Inc13.82-1646.92%
SABSSAB Biotherapeutics Inc14.14-1682.29%
NAGENiagen Bioscience Inc14.82-1758.62%
INCYIncyte Corp15.82-1871.05%
REGNRegeneron Pharmaceuticals Inc15.86-1874.87%
PBYIPuma Biotechnology Inc17.32-2038.18%
CPRXCatalyst Pharmaceuticals Inc17.44-2052.02%
EXELExelixis Inc17.54-2063.07%
TGTXTG Therapeutics Inc18.97-2222.91%
MDXGMimedx Group Inc20.55-2400.48%
XOMAXOMA Royalty Corp22.87-2660.48%
ARGXArgen X SE24.30-2819.80%
CTMXCytomX Therapeutics Inc24.82-2878.35%
XOMAOXOMA Royalty Corp25.34-2936.97%
HALOHalozyme Therapeutics Inc25.62-2968.19%
XOMAPXOMA Royalty Corp25.67-2973.38%
VRTXVertex Pharmaceuticals Inc27.99-3233.59%
RPRXRoyalty Pharma plc - Class A28.69-3311.14%
SLNOSoleno Therapeutics Inc29.02-3347.83%
ASNDAscendis Pharma A/S30.09-3467.63%
LGNDLigand Pharmaceuticals Inc - Class B37.91-4343.68%
BMRNBiomarin Pharmaceutical Inc42.21-4824.98%
KRYSKrystal Biotech Inc45.34-5175.52%
ONCBeiGene Ltd69.54-7884.01%
PHARPharming Group N.V.75.03-8497.99%
TECHBio-Techne Corp101.96-11512.72%
VCELVericel Corp109.92-12404.05%
ALNYAlnylam Pharmaceuticals Inc117.96-13304.43%
GMABGenmab140.29-15803.46%
TLXTelix Pharmaceuticals Ltd162.15-18250.59%
CORTCorcept Therapeutics Inc212.86-23926.22%